Clinical features of the myasthenic syndrome arising from mutations in GMPPB

Clinical features of the myasthenic syndrome arising from mutations in GMPPB

Congenital myasthenic syndrome (CMS) due to mutations in GMPPB has recently been reported confirming the importance of glycosylation for the integrity of neuromuscular transmission.Review of case notes of patients with mutations in GMPPB to identify the associated clinical, neurophysiological, patho...

Full description

Bibliographic Details
Main Authors:	Rodríguez Cruz, P, Belaya, K, Basiri, K, Sedghi, M, Farrugia, M, Holton, J, Liu, W, Maxwell, S, Petty, R, Walls, T, Kennett, R, Pitt, M, Sarkozy, A, Parton, M, Lochmüller, H, Muntoni, F, Palace, J, Beeson, D
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2016

Similar Items

Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.
by: Basiri, K, et al.
Published: (2013)

Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome
by: Luo, S, et al.
Published: (2017)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
by: Finlayson, S, et al.
Published: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
by: Finlayson, S, et al.
Published: (2013)

Limb ⁃ girdle muscular dystrophy with congenital myasthenic syndrome caused by GMPPB gene mutation: one case report
by: LI Ran, et al.
Published: (2023-09-01)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
by: Belaya, K, et al.
Published: (2012)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
by: Chaouch, A, et al.
Published: (2012)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
by: Cossins, J, et al.
Published: (2013)

Consequences of GMPPB deficiency for neuromuscular development and maintenance
by: Mona K. Schurig, et al.
Published: (2024-02-01)

The congenital myasthenic syndromes.
by: Palace, J, et al.
Published: (2008)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
by: Belaya, K, et al.
Published: (2012)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
by: Belaya, K, et al.
Published: (2012)

Therapeutic strategies for congenital myasthenic syndromes
by: Lee, M, et al.
Published: (2018)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
by: Cossins, J, et al.
Published: (2013)

Congenital myasthenic syndromes.
by: Beeson, D, et al.
Published: (1997)

Congenital myasthenic syndromes: an update.
by: Finlayson, S, et al.
Published: (2013)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
by: Cossins, J, et al.
Published: (2012)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
by: Kinali, M, et al.
Published: (2008)

Congenital myasthenic syndromes and the neuromuscular junction.
by: Cruz, P, et al.
Published: (2014)

Congenital myasthenic syndrome caused by mutations in DPAGT.
by: Klein, A, et al.
Published: (2015)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
by: Jephson, C, et al.
Published: (2010)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
by: Rodríguez Cruz, P, et al.
Published: (2018)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
by: Zoltowska, K, et al.
Published: (2013)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
by: Zoltowska, K, et al.
Published: (2013)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
by: Beeson, D, et al.
Published: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D, et al.
Published: (2008)

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
by: Klein, A, et al.
Published: (2013)

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children
by: Klein, A, et al.
Published: (2013)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
by: Lashley, D, et al.
Published: (2009)

126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands.
by: Beeson, D, et al.
Published: (2005)

Therapy of myasthenic syndrome
by: Palace, J
Published: (2012)

Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface
by: Webster, R, et al.
Published: (2014)

Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface.
by: Webster, R, et al.
Published: (2014)

186th ENMC international workshop: congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands.
by: Chaouch, A, et al.
Published: (2012)

186th ENMC International Workshop: Congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands
by: Chaouch, A, et al.
Published: (2012)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)

Myasthenic syndromes due to defects in COL13A1 and in the N‐linked glycosylation pathway
by: Beeson, D, et al.
Published: (2018)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
by: Burke, G, et al.
Published: (2006)

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era
by: Thompson, R, et al.
Published: (2018)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
by: Vincent, A, et al.
Published: (1993)